The role of antiphospholipid antibodies on the pathogenesis of habitual pregnancy loss

O. N. Arzhanova; T. N. Shliakhtenko; S. А. Selkov; T. А. Pluzhnikova; О. V. Tishkevitch; А. V. Fedorenko; E. A. Shapovalova

doi:10.17816/JOWD90372

Journal of obstetrics and women's diseases ›› 2002, Vol. 51 ›› Issue (2) :18 -22. DOI: 10.17816/JOWD90372

Scientific activity

review-article

The role of antiphospholipid antibodies on the pathogenesis of habitual pregnancy loss

Author information +

History +

PDF (127KB)

Abstract

Clinical and anamnesis analysis as well as analysis of the course and outcome of the present pregnancy was performed on 595 patients with complicated obstetrical and gynecological history (COGH) — habitual pregnancy loss, infertility, genital chronic processes. Control groupconsisted of 5O healthy women. Immunofluorescent analysis was used to reved antiphospholipid antibodies on blood plasma. Antiphospholipid antibodies were found in 42% of COGH women. No antiphospholipid antibodies were seen in the control group. In all patients of the studied groupthe course of pregnancy was accompanied with signs of threatened abortion, gestosis. 29% (p< O, O1) patients had preterm labor and spontaneous abortion occurred in 18% (p< O, O1) of cases. Perinatal mortality was 9, 8%±4, 16.

Keywords

the role of antiphospholipid antibodies / AFA / pathogenesis of miscarriage

Cite this article

Download citation ▾

O. N. Arzhanova, T. N. Shliakhtenko, S. А. Selkov, T. А. Pluzhnikova, О. V. Tishkevitch, А. V. Fedorenko, E. A. Shapovalova. The role of antiphospholipid antibodies on the pathogenesis of habitual pregnancy loss. Journal of obstetrics and women's diseases, 2002, 51(2): 18-22 DOI:10.17816/JOWD90372

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Аббасси Х., Мищенко А. Л.: Рецидивирующий тромбоз у беременных с “ВА"//Акуш. и гин. — № 6. -1996. -С. 17-20.

[2]	Бар каган 3. С. Патогенез, диагностика и принципы терапии ДВС-синдрома. //Маtеrіа Medica, № 1 (13). -1997. -С. 5-14.

[3]	Климов А. Н. Аутоиммунная теория патогенеза и концепция модифицированных липопротеидов/ /Вестн. АМН СССР. -1990. -№11. -С. 30-36.

[4]	Макацария А. Д. Тромбофилия и беременность. //Вест. Рос. Ассоц. Акуш. и гин. — № 1. — 1994. —С. 76-85.

[5]	Насонов Е. Л.Антифосфолипидный синдром. Клиническая и иммунологическая характеристика. //Тер.Архив. -№ 7. -1989. -С. 5-13.

[6]	ACOG. Antipospholihid syndrom, — № 244. — 1998.

[7]	Bick R. L., Madden J, Heller К. B. Reccurent miscarriage: cause, evaluation and treatment//Medscape Womens heath,3 (3),1998.

[8]	Charavi A. E., Wilson W. A. //The syndrom of trombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antipospholihid antibodies: Hughes syndrom, Lupus 5(5): 1996, p. 343-344.

[9]	Hughes G. R. V. //The antipospholihid syndrom. Lupus 5 (5): 1996, p. 345-346)8)

[10]	Gordon C, Kilby M. D., Use of intravenous immunoglobulin therapy in SLE and antipospholihid antibodies syndrom//Lupus (70),1998, p. 429-433.

[11]	Kol L., Libby P. Molecular mediators of arterial inflammation: a role for microbal products? Am Heart J 1999; 138 (5): 450-452.

[12]	Lockshin M. D., Antipospholihid antibodies//JAMA, v. 277, №. 19,1997, p. 1549-1551

[13]	Regnstrom J., Nilsson J. Lipid oxidation fnd inflammation-induced intimal fibrosis//J. Lab. Clin. Med. — 1994. -Vol. 166. -P. 162-168.

[14]	Vianna J. L., Khamashta M. A., Oroli — ros J, et al: Comparison of the primary and secondary ntipospholihid syndrome: A European multicenter study of 114 patients. // Am J Med 96: 1994 p. 3-9.